Latest Breaking News On - Therapeutics esperion - Page 1 : comparemela.com

ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) Esperion (NASDAQ: ESPR) today announced the appointment of Seth H.Z. Fischer as a Class III director, with a term expiring at

United statesSheldon koenigSethhz fischerCordis corporationBiosig technologies incMcneil pharmaceuticalsVivus incUs airLipid management companyMarinus pharmaceuticalsExchange commissionOhio universityAgile therapeutics incSpectrum pharmaceuticals incAmerica pharmaceuticalsAgile therapeutics